| Trial ID: | L0435 |
| Source ID: | NCT05373680
|
| Associated Drug: |
Metformin
|
| Title: |
Efficacy and Safety of Metformin Versus Empagliflozin on Chronic Kidney Disease Progression
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Renal Insufficiency, Chronic
|
| Interventions: |
DRUG: Metformin|DRUG: Empagliflozin|OTHER: Control
|
| Outcome Measures: |
Primary: Change in estimated glomerular filtration rate (eGFR) values from baseline, This will be achieved by measuring the serum creatinine levels and then eGFR values will be calculated., Period of 12 months|Change in albumin or protein excretion values from baseline, This will be achieved by measuring the urinary albumin or protein:creatinine ratio from a spot urine test in a morning sample., Period of 12 months |
|
| Sponsor/Collaborators: |
Sponsor: Tanta University | Collaborators: Mansoura University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2|PHASE3
|
| Enrollment: |
90
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2022-01-01
|
| Completion Date: |
2024-06
|
| Results First Posted: |
|
| Last Update Posted: |
2023-04-18
|
| Locations: |
Mansoura University, Mansoura, Dakahlia Governorate, Egypt|Tanta University Teaching Hospitals, Tanta, Gharbia Governorate, Egypt
|
| URL: |
https://clinicaltrials.gov/show/NCT05373680
|
